SCHEMBL9687066

SCHEMBL9687066

Cc1ccc(Cn2c(NC3CCN(C)CC3)nc3cccnc32)o1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.38
TP53 P04637 1/20 0.38
DNMT1 P26358 4/20 0.37
EHMT2 Q96KQ7 4/20 0.37
ALDH1A1 P00352 2/20 0.36
SSTR5 P35346 3/20 0.35
BRD4 O60885 2/20 0.35
H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 P62805 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
SSTR4 P31391 2/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9630643 0.92 MEN1 (0.42) MEN1KMT2ATP53ALDH1A1SSTR4
Oxalic Acid SCHEMBL9630637 0.92 MEN1 (0.42) MEN1KMT2ATP53ALDH1A1SSTR4
Noberastine SCHEMBL18424 0.88 NR4A2 (0.45) NPC1RAB9AMEN1KMT2ATSHR
SCHEMBL9629623 0.87 WHR1 (0.39) NPC1RAB9AMEN1KMT2ATSHR
Fumaric Acid SCHEMBL9629725 0.87 MEN1 (0.41) MEN1KMT2ATP53ALDH1A1SSTR4
SCHEMBL9629492 0.86 MEN1 (0.41) MEN1KMT2ATP53ALDH1A1SSTR5
SCHEMBL9630536 0.86 MEN1 (0.42) MEN1KMT2ATP53ALDH1A1SSTR5
SCHEMBL9630210 0.86 EED (0.39) NPC1RAB9AMEN1KMT2ATSHR
SCHEMBL9687543 0.85 NOS2 (0.52) MEN1KMT2ATSHRALDH1A1MAPT
SCHEMBL14198334 0.85 TSHR (0.52) NPC1RAB9AMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0295742-B1 NOVEL N-(4-PIPERIDINYL) BICYCLIC CONDENSED 2-IMIDAZOLAMINE DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-26 EP claimed
US-4897401-A N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases JANSSEN PHARMACEUTICAL N.V. (BE) 1990-01-30 US claimed
EP-0295742-A1 Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-21 EP claimed
US-5006527-A Antihistamines, antiallergens JANSSEN PHARMACEUTICA N.V. (BE) 1991-04-09 US disclosed
US-4897401-A N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases JANSSEN PHARMACEUTICAL N.V. (BE) 1990-01-30 US disclosed
EP-0295742-A1 Novel N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1988-12-21 EP disclosed
JP-1025776-A 0001-01-01 JP disclosed